Back
Previous product
Palmer's Cocoa Butter Formula Swivel Stick Lip Moisturizer 0.5 oz on Sale Original price was: $3.99.Current price is: $3.19.
Next product
Pampers Baby Clean Wipes Fresh Scented Pop-Top 72 Count Cheap Original price was: $4.99.Current price is: $3.99.

Pamidronate Disodium for Injection 3mg/mL Single Dose Vial 10 mL on Sale

Original price was: $43.95.Current price is: $26.37.

SKU: US-6666777591880 Category:
Description

Description

Pamidronate Disodium for Injection 3mg/mL Single Dose Vial 10 mL

Pamidronate is used to treat high blood calcium levels and certain bone problems (bone metastases/lesions) that may occur with some types of cancer. It is also used to treat a certain type of bone disease (Paget’s disease) that causes abnormal and weak bones.

Pamidronate injection is used to treat hypercalcemia (too much calcium in the blood) that may occur in patients with some types of cancer.

 

INDICATIONS AND USAGE

Hypercalcemia of Malignancy 

Pamidronate disodium, in conjunction with adequate hydration, is indicated for the treatment of moderate or severe hypercalcemia associated with malignancy, with or without bone metastases.

Patients who have either epidermoid or non-epidermoid tumors respond to treatment with pamidronate disodium. Vigorous saline hydration, an integral part of hypercalcemia therapy, should be initiated promptly and an attempt should be made to restore the urine output to about 2 L/day throughout treatment. Mild or asymptomatic hypercalcemia may be treated with conservative measures (i.e., saline hydration, with or without loop diuretics). Patients should be hydrated adequately throughout the treatment, but overhydration, especially in those patients who have cardiac failure, must be avoided. Diuretic therapy should not be employed prior to correction of hypovolemia. The safety and efficacy of pamidronate disodium in the treatment of hypercalcemia associated with hyperparathyroidism or with other non-tumor-related conditions has not been established.

Paget’s Disease 

Pamidronate disodium is indicated for the treatment of patients with moderate to severe Paget’s disease of bone. The effectiveness of pamidronate disodium was demonstrated primarily in patients with serum alkaline phosphatase ≥ 3 times the upper limit of normal. Pamidronate disodium therapy in patients with Paget’s disease has been effective in reducing serum alkaline phosphatase and urinary hydroxyproline levels by ≥ 50% in at least 50% of patients, and by ≥ 30% in at least 80% of patients. Pamidronate disodium therapy has also been effective in reducing these biochemical markers in patients with Paget’s disease who failed to respond, or no longer responded to other treatments.

Osteolytic Bone Metastases of Breast Cancer and Osteolytic Lesions of Multiple Myeloma

Pamidronate disodium is indicated, in conjunction with standard antineoplastic therapy, for the treatment of osteolytic bone metastases of breast cancer and osteolytic lesions of multiple myeloma. The pamidronate disodium treatment effect appeared to be smaller in the study of breast cancer patients receiving hormonal therapy than in the study of those receiving chemotherapy, however, overall evidence of clinical benefit has been demonstrated

 

Shipping & Delivery

We accept returns on non-sale items that are in original packaging, unused, and unwashed within 30 days of receipt. Please follow our returns/exchanges process below. If items do not meet our requirements for return, they will be shipped back to you in lieu of a refund. Shipping and handling charges are non-refundable (exceptions may apply).

Returns & Exchanges Process: If item(s) fit within our returns guidelines found in the Returns. Please allow 7-10 business days for the credit to appear on your account after your return is processed.